AstraZeneca said on Friday it has sued the U.S. government to block parts of a program that gives the Medicare health insurance plan the power to negotiate lower drug prices.
Tag Archive for: AstraZeneca
AstraZeneca is facing two London lawsuits, including one from the husband of a woman who died after receiving the Anglo-Swedish drugmaker’s COVID-19 vaccine, in the first of potentially dozens of cases brought in England.
The U.S. Food and Drug Administration on Monday approved Pfizer’s (PFE.N) respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.
AstraZeneca is China’s largest drugmaker and is doubling down on the world’s No.2 pharmaceutical market amid slumping sales of its COVID vaccine.
The therapy, branded as Beyfortus, will be available in the U.S. ahead of the upcoming 2023-24 RSV season, Sanofi said.
The company said it will continue with its plan to file data from the trial with the FDA, soothing some investor concerns.
The British company also said Sharon Barr, head of research and development at Alexion, would succeed Mene Pangalos, the long-time biopharmaceuticals head of research at AstraZeneca.
The Medicines and Healthcare products Regulatory Agency said AstraZeneca’s GLP-1 drug for type 2 diabetes, called exenatide and marketed as Bydureon, was also included in the review.
Beyfortus, which received FDA Fast Track for this designation, is a monoclonal antibody with activity against RSV.
Although an experimental precision drug slowed progression of lung cancer in a late-stage trial, the company’s shares fell as much as 6% as analysts said the benefits may not be as pronounced as hoped.
